Provention Bio diabetes drug to cost $13,850/vial
The US Food and Drug Administration (FDA) approved use of the drug, to be sold under brand name Tzield, for delaying the onset of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
teplizumab
FDA approval of Provention Bio’s Teplizumab could bring first disease-modifying therapy to type 1…
If Provention Bio’s rolling Biologic License Application (BLA) submission to the FDA for teplizumab is approved, teplizumab will…